Bratton Capital Management, L.P. has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing its equity portfolio holdings as of September 30, 2026. The filing identifies John S. Cochran, Vice President at the firm, as the authorized signatory responsible for the report.
The report lists a total of one equity security held by the firm during the specified period. The sole holding identified is Aquestive Therapeutics Inc., a company listed under ticker symbol 03843E104. The filing indicates that the position was held for the entire reporting period.
According to the information table provided in the filing, the total number of shares held for this security is 9,810,958. The filing further notes that this position is held as a Sole voting power and Sole dispositive power.
